Agenus reported $252.95M in Sales Revenues for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US $ 14342M 383M
Acceleron Pharma XLRN:US $ 34.2M 6.26M
Agenus AGEN:US $ 252.95M 242.22M
Amgen AMGN:US $ 6706M 180M
AstraZeneca AZN:LN 9866M 1646M
Bristol Myers Squibb BMY:US $ 11624M 79M
Celldex Therapeutics CLDX:US $ 0.15M 3.33M
Chemocentryx CCXI:US $ 17.74M 15.93M
CSL CSL:AU $ 4.57B 1.17B
Dicerna Pharmaceuticals DRNA:US $ 62.95M 21.62M
Dynavax Technologies DVAX:US $ 108.27M 55.5M
Eli Lilly And LLY:US $ 6772.8M 32.7M
Flexion Therapeutics FLXN:US $ 21.33M 6.85M
Genocea Biosciences GNCA:US $ 1.64M 1.64M
Gilead Sciences GILD:US $ 7421M 1204M
Glaxosmithkline GSK:US $ 9077M 985M
GlaxoSmithKline GSK:LN 9077M 985M
Immunogen IMGN:US $ 9.21M 7.74M
Intrexon XON:US $ 21.56M 12.02M
Jiangsu Hengrui Me. 600276:CH CH 6901.43M 532.94M
Johnson & Johnson JNJ:US $ 23338M 26M
Karyopharm Therapeutics KPTI:US $ 37.69M 15.09M
Macrogenics MGNX:US $ 15.66M 15.1M
Merck MRK:GR € 4973M 103M
Merk MRK:US $ 13154M 1752M
Northwest Biotherapeutics NWBO:US 350K 66K
Novartis NOVN:VX SF 13367M 73M
Novavax NVAX:US $ 178.84M 119.17M
Pfizer PFE:US $ 24094M 5117M
Regeneron Pharmaceuticals REGN:US $ 3452.8M 1685.7M
Rigel Pharmaceuticals RIGL:US $ 21.54M 4.72M
Sangamo Biosciences SGMO:US $ 28.56M 0.69M
Veracyte VCYT:US $ 60.37M 5.26M
YTE INCY:US $ 812.99M 107.28M